Prevalence of oral HPV infection in the United States, 2009-2010.
about
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa RicaCancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisionsSignificance of Human Papillomavirus in Head and Neck CancersRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerEpidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell CarcinomaThe "HPV Discussion": Effective Use of Data to Deliver Recommendations to Patients Impacted by HPVTargeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for TherapyOral human papillomavirus infection and head and neck cancers in HIV-infected individualsPrevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic ReviewDiscussing the diagnosis of HPV-OSCC: common questions and answersEUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infectionWhat is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. MenCurrent Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.HPV and cancer of the oral cavityPrevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject DrugsCurrent and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma.Management of Oropharyngeal Cancer in the HPV Era.The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link - A Systematic Review.Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinomaSharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know.Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published dataHuman papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United StatesTrends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952-2006: an age-period-cohort analysisDevelopment and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents.Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.Prospects for prevention of HPV-driven oropharynx cancer.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, Peru.PPARγ in head and neck cancer preventionCounseling the patient with potentially HPV-related newly diagnosed head and neck cancerBehavioral Decision Research Intervention Reduces Risky Sexual Behavior.High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010.Hybrid Capture 2 is as effective as PCR testing for high-risk human papillomavirus in head and neck cancers.Prevalence of cervical and oral human papillomavirus infections among US womenClinical and scientific impact of human papillomavirus on head and neck cancer.Oral Human Papillomavirus (HPV) Infection among Unvaccinated High-Risk Young Adults
P2860
Q21089767-236358DD-7420-4F28-AD9B-FA4F013819B4Q26261171-68CC8911-7CC3-4C0E-B98B-F2EB35F43880Q26777883-6E384577-8D30-48CE-8CF5-0E3E9525A1A7Q26782255-DE67C4BD-8A09-4603-9F9A-03CFDDDD4ADCQ26782499-C5B4488A-E694-4F40-972E-24BB2F8F8D64Q26798297-D92B569B-6FBB-4776-BA11-2F8BE4664E22Q26824925-908D293F-DAE0-4636-B7B3-DA3B8CF6BDC7Q26825257-C0017264-D60C-47A9-A9D2-D4D3F7AAFBACQ26851922-6A691C8F-FAE0-4FA6-930D-74A8D03328B6Q27000693-95ACFBEC-77C1-465C-884E-23C8F03CD814Q27010432-22C9F74D-4B5E-4E10-99F2-6FAF2BC9E27AQ27026269-45235BA7-8CA9-4990-B464-38F984D31C2DQ27312453-1489F158-7B4B-40B9-B22C-981D9907FC5DQ27347744-8DA5C21F-7A06-4BC0-BC5C-C03B7A2E645EQ28072364-B699C487-8258-48E9-84FD-DFD3E9D2F970Q28081656-75C9D78A-D514-41BD-8065-5C6833ABBFDEQ28551118-B0232AC8-EFB6-4920-9BE5-AAC532348FDCQ30235327-C934F475-88C6-445B-A84C-EE0253D721D8Q30248326-8025D415-169D-4C64-9570-184B872A96A7Q30251408-EB7B27DE-523D-4574-A29A-08C413EF3C62Q30251750-A6FD1545-7E4A-4218-ADE5-7F5DC5855AF3Q30354637-12AE62C0-06B5-460D-AE71-A5731B204321Q30491128-9239A7EF-A006-436D-B286-D99ADB10F586Q30540849-B6CD13C3-6054-44D6-AAE2-B8D54552BAD7Q31136389-CEBCED7B-A329-4C5B-BD1E-816C20C1752FQ33577175-7F9A804E-5568-4007-84F5-A814415A3E24Q33617489-6D0277F7-69BA-4C95-8E14-8E34F1D0D572Q33645571-69170C5C-79BE-4DEF-8FC1-8BBA6FD369D1Q33712114-A9584503-6AA8-4B73-AB22-5BD11A8BCBF4Q33759930-239634C9-3852-4986-BECE-930D8A94D733Q33770030-CFEAE78D-2A79-4AAB-88B5-262DD6A75FCFQ33777361-D8E2CFAD-0390-4C03-B8F9-8B8B83A5A74DQ33896090-630DC0D2-ABB3-4CBC-BF0D-90D66BBBC581Q33908473-46F7E7BF-8491-4DB1-9DDB-6EB1149D1BACQ33924824-2E5AE5B6-9760-403B-8C1E-9FCD3001C2FFQ33947827-D8BA1529-BF33-4E9A-A240-E54D5FF192D9Q33976804-CD67CE09-0572-49FF-B357-D878A74D4FF2Q34007201-49B08B63-0915-4242-A6E5-AD53C136DA5DQ34031281-0EC4947B-18A8-4323-AA6D-52C10A73F921Q34309940-CD8411BA-B601-482A-B3B3-BF601AC39456
P2860
Prevalence of oral HPV infection in the United States, 2009-2010.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prevalence of oral HPV infection in the United States, 2009-2010.
@en
Prevalence of oral HPV infection in the United States, 2009-2010.
@nl
type
label
Prevalence of oral HPV infection in the United States, 2009-2010.
@en
Prevalence of oral HPV infection in the United States, 2009-2010.
@nl
prefLabel
Prevalence of oral HPV infection in the United States, 2009-2010.
@en
Prevalence of oral HPV infection in the United States, 2009-2010.
@nl
P2093
P2860
P356
P1476
Prevalence of oral HPV infection in the United States, 2009-2010.
@en
P2093
Anil K Chaturvedi
Barry I Graubard
Lisa Kahle
Maura L Gillison
Robert K L Pickard
Tatevik Broutian
Weihong Xiao
Zhen-you Tong
P2860
P304
P356
10.1001/JAMA.2012.101
P407
P577
2012-01-26T00:00:00Z